NDLI: Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

Content Provider	Springer Nature Link
Author	Prizment, Anna E. Folsom, Aaron R. Dreyfus, Jill Anderson, Kristin E. Visvanathan, Kala Joshu, Corinne E. Platz, Elizabeth A. Pankow, James S.
Copyright Year	2013
Abstract	Many studies, including the Atherosclerosis Risk in Communities (ARIC) cohort, reported a positive association between plasma C-reactive protein (CRP)—a biomarker of low-grade chronic inflammation—and colorectal cancer risk, although it is unclear whether the association is causal. Our aims were to assess the associations of a CRP genetic risk score (CRP-GRS) created from single-nucleotide polymorphisms (SNPs) with colorectal cancer risk, as well as examine plasma CRP and CRP-GRS in relation to common cancers in the ARIC cohort.Cox proportional hazards models were used to prospectively estimate hazard ratios (HRs) and 95 % confidence interval (95 % CI) of total, colorectal, lung, prostate, and breast cancers in relation to: (1) CRP-GRS among 8,657 Whites followed in 1987–2006 and (2) log-transformed plasma CRP among 7,603 Whites followed in 1996–2006. A weighted CRP-GRS was comprised of 20 CRP-related SNPs located in/near CRP, APOC1, HNF1A, LEPR, and 16 other genes that were identified in genome-wide association studies.After multivariable adjustment, one standard deviation increment of the CRP-GRS was associated with colorectal cancer risk (HR 1.19; 95 % CI 1.03–1.37), but not with any other cancer. One unit of log-transformed plasma CRP was associated with the risk of total, colorectal, lung, and breast cancers: HRs (95 % CIs) were 1.08 (1.01–1.15), 1.24 (1.01–1.51), 1.29 (1.08–1.54), and 1.27 (1.07–1.51), respectively. HRs remained elevated, although lost statistical significance for all but breast cancer, after excluding subjects with <2 years of follow-up.The study corroborates a causative role of chronic low-grade inflammation in colorectal carcinogenesis.
Starting Page	2077
Ending Page	2087
Page Count	11
File Format	PDF
ISSN	09575243
Journal	Cancer Causes & Control
Volume Number	24
Issue Number	12
e-ISSN	15737225
Language	English
Publisher	Springer Netherlands
Publisher Date	2013-09-14
Publisher Place	Dordrecht
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Inflammation CRP Cancer risk Genetic risk score Genetic polymorphism ARIC cohort Cancer Research Biomedicine general Oncology Public Health Epidemiology Hematology
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

C-reactive protein and colorectal adenoma in the CLUE II cohort

Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis

The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation

Common genetic polymorphisms of AURKA and prostate cancer risk

C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy)

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

Similar Documents

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

C-reactive protein and colorectal adenoma in the CLUE II cohort

Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis

The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation

Common genetic polymorphisms of AURKA and prostate cancer risk

C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy)

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study